v3.25.4
Note 9 - Segment Information and Disaggregated Revenue - Operations by Business Segment (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Jun. 30, 2025
Sales, net $ 11,280 $ 12,614 $ 23,969 $ 26,231  
Cost of sales 11,251 11,443 22,921 23,689  
Gross profit 29 1,171 1,048 2,542  
Depreciation 78 83 155 171  
Capital Expenditures 24 29 197 85  
Assets 23,547   23,547   $ 24,901
Contract Manufacturing [Member]          
Sales, net 10,920 11,670 23,087 24,643  
Cost of sales 10,897 10,873 22,090 22,668  
Gross profit 23 797 997 1,975  
Depreciation 77 83 154 170  
Capital Expenditures 17 29 182 85  
Assets 18,917   18,917    
Other Nutraceutical Business [Member]          
Sales, net 360 944 882 1,588  
Cost of sales 354 570 831 1,021  
Gross profit 6 374 51 567  
Depreciation 1 0 1 1  
Capital Expenditures 7 0 15 0  
Assets 4,630   4,630    
UNITED STATES          
Sales, net 8,705 10,259 19,358 21,691  
Assets         24,901
UNITED STATES | Contract Manufacturing [Member]          
Sales, net 8,345 9,315 18,476 20,103  
Assets         20,278
UNITED STATES | Other Nutraceutical Business [Member]          
Sales, net 360 944 882 1,588  
Assets         $ 4,623
Non-US [Member]          
Sales, net 2,575 2,355 4,611 4,450  
Non-US [Member] | Contract Manufacturing [Member]          
Sales, net 2,575 2,355 4,611 4,450  
Non-US [Member] | Other Nutraceutical Business [Member]          
Sales, net $ 0 $ 0 $ 0 $ 0